EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Placental growth factor as a sensitive biomarker for vascular cognitive impairment

Jason D Hinman iD, Fanny Elahi, Davis Chong, Hannah Radabaugh, Adam Ferguson, Pauline Maillard, Jeffrey F Thompson, Gary A Rosenberg, Abhay Sagare, Abhay Moghekar, Hanzhang Lu, Tiffany Lee und 11 weitere

Alzheimer's & Dementia · 2023-08 · 19 (8) · 3519-3527

DOI: 10.1002/alz.12974 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Alzheimer's & Dementia, online erschienen am 23.02.2023. Verfasst von Jason D Hinman und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Cognitive Dysfunction. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION High‐performing biomarkers measuring the vascular contributions to cognitive impairment and dementia are lacking. METHODS Using a multi‐site observational cohort study design, we examined the diagnostic accuracy of plasma placental growth factor (PlGF) within the MarkVCID Consortium ( n = 335; CDR 0‐1). Subjects underwent clinical evaluation, cognitive testing, MRI, and blood sampling as defined by Consortium protocols. RESULTS In the prospective population of 335 subjects (72.2 ± 7.8 years of age, 49.3% female), plasma PlGF (pg/mL) shows an ordinal odds ratio (OR) of 1.16 (1.07‐1.25; P = .0003) for increasing Fazekas score and ordinal OR of 1.22 (1.14‐1.32; P < .0001) for functional cognitive impairment measured by the Clinical Dementia Rating scale. We achieved the primary study outcome of a site‐independent association of plasma PlGF (pg/mL) with white matter injury and cognitive impairment in two of three study cohorts. Secondary outcomes using the full MarkVCID cohort demonstrated that plasma PlGF can significantly discriminate individuals with Fazekas ≥ 2 and CDR = 0.5 (area under the curve [AUC] = 0.74) and CDR = 1 (AUC = 0.89) from individuals with CDR = 0. DISCUSSION Plasma PlGF measured by standardized immunoassay functions as a stable, reliable, diagnostic biomarker for cognitive impairment associated with substantial white matter burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionFemaleHumansMaleMiddle AgedBiomarkersPlacenta Growth FactorProspective StudiesAgedAged, 80 and over

Stichwörter der Autor:innen

biomarkerdiagnosisplacental growth factorvascular cognitive impairment

Substanzen

BiomarkersPlacenta Growth Factor

Autor:innen und Institutionen

  • Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Department of Neurology, Department of Veterans Affairs, West Los Angeles Veterans Association Medical Center, Los Angeles, California, USA.
  • Memory and Aging Center, Weill Institute for Neuroscience, University of California San Francisco, San Francisco, California, USA.
  • Department of Neurology, Department of Veterans Affairs, San Francisco Veterans Association Medical Center, San Francisco, California, USA.
  • Department of Neurological Surgery, Weill Institute for Neuroscience, University of California San Francisco, San Francisco, California, USA.
  • Department of Neurology, University of California Davis, Davi, California, USA.

ORCID-Profile: Jason D Hinman

Förderung

  • NINDS NIH HHS
  • NIH HHS
  • NIA NIH HHS
  • National Institutes of Health

Zitieren

APA

Hinman, J. D., Elahi, F., Chong, D., Radabaugh, H., Ferguson, A., Maillard, P., Thompson, J. F., Rosenberg, G. A., Sagare, A., Moghekar, A., Lu, H., Lee, T., Wilcock, D., Satizabal, C. L., Tracy, R., Seshadri, S., Schwab, K., Helmer, K., Singh, H., …, & Kramer, J. (2023). Placental growth factor as a sensitive biomarker for vascular cognitive impairment. Alzheimer's & Dementia, 19(8), 3519-3527. https://doi.org/10.1002/alz.12974

Vancouver

Hinman JD, Elahi F, Chong D, Radabaugh H, Ferguson A, Maillard P, et al. Placental growth factor as a sensitive biomarker for vascular cognitive impairment. Alzheimer's & Dementia. 2023;19(8):3519-3527. doi:10.1002/alz.12974

BibTeX
@article{Hinman2023,
  author = {Hinman, Jason D and Elahi, Fanny and Chong, Davis and Radabaugh, Hannah and Ferguson, Adam and Maillard, Pauline and Thompson, Jeffrey F and Rosenberg, Gary A and Sagare, Abhay and Moghekar, Abhay and Lu, Hanzhang and Lee, Tiffany and Wilcock, Donna and Satizabal, Claudia L and Tracy, Russell and Seshadri, Sudha and Schwab, Kristin and Helmer, Karl and Singh, Herpreet and Kivisäkk, Pia and Greenberg, Steve and DeCarli, Charlie and Kramer, Joel},
  title = {Placental growth factor as a sensitive biomarker for vascular cognitive impairment},
  journal = {Alzheimer's & Dementia},
  year = {2023},
  volume = {19},
  number = {8},
  pages = {3519--3527},
  doi = {10.1002/alz.12974}
}
Kostenlos starten →